Clinical Trial Update: QLS12010 in Participants With Moderate-to-severe Rheumatoid Arthritis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial of QLS12010 in moderate-to-severe rheumatoid arthritis is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• QLS12010

Snippet

Sponsor: Qilu Pharmaceutical Co., Ltd. | Conditions: Rheumatoid Arthritis (RA) | Phase 2 | Status: NOT_YET_RECRUITING